Benzonatate Toxicity: Nothing to Cough At.

J Anal Toxicol

North Carolina Office of the Chief Medical Examiner, Raleigh, NC, USA.

Published: June 2017

Download full-text PDF

Source
http://dx.doi.org/10.1093/jat/bkx021DOI Listing

Publication Analysis

Top Keywords

benzonatate toxicity
4
toxicity cough
4
benzonatate
1
cough
1

Similar Publications

Benzonatate as a local anesthetic.

PLoS One

April 2023

Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts, United States of America.

Introduction: Benzonatate is an FDA-approved antitussive agent that resembles tetracaine, procaine, and cocaine in its chemical structure. Based on structural similarities to known local anesthetics and recent findings of benzonatate exerting local anesthetic-like effects on voltage-gated sodium channels in vitro, we hypothesized that benzonatate will act as a local anesthetic to yield peripheral nerve blockade.

Methods: Benzonatate was injected at the sciatic nerve of Sprague-Dawley rats.

View Article and Find Full Text PDF

Objective: To review the available literature regarding the treatment effects and efficacy of benzonatate needed to better inform patients, providers, and regulators evaluating its role in modern medical therapies.

Data Sources: Comprehensive literature searches were conducted in PubMed, Embase (Elsevier), Cochrane Library, and Scopus for original research articles evaluating the effectiveness, tolerability, and safety profile of benzonatate from January 1956 through August 2022.

Study Selection And Data Extraction: The identified studies were screened for relevance and then assessed for inclusion through a full-text review, data extraction, and quality assessment by multiple reviewers using the online software Covidence.

View Article and Find Full Text PDF

Background And Objectives: Adverse events (AE), including death, occur in children with benzonatate use. This study aims to understand recent trends in benzonatate exposure and clinical consequences in pediatric patients.

Methods: This retrospective analysis of data from IQVIA pharmacy drug dispensing, National Poison Data System, National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project, FDA Adverse Event Reporting System, and the medical literature evaluated exposure trends and medication-related AEs with benzonatate.

View Article and Find Full Text PDF

Background: Benzonatate is a commonly prescribed medication that can be lethal in acute overdose of a small number of capsules.

Objective: This was a systematic review to describe the course of severe poisoning and deaths from benzonatate supplemented with the National Poison Data System (NPDS) fatalities module.

Methods: The NPDS was queried from 2000 to 2018 for benzonatate fatalities.

View Article and Find Full Text PDF

The Antitussive Benzonatate Is Not Tumorigenic in Rodent Carcinogenicity Studies.

Toxicol Pathol

August 2018

6 Pfizer Inc., Drug Safety Research and Development, Groton, Connecticut, USA.

Benzonatate is a peripheral oral antitussive that dampens the activity of cough stretch receptors. Rodent carcinogenicity studies were performed in Tg.rasH2 mice and Wistar Han rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!